Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2000
03/02/2000WO2000011206A1 Methods and systems for predicting protein function
03/02/2000WO2000011205A1 Optical oxidative enzyme-based sensors
03/02/2000WO2000011204A2 Homer interacting proteins
03/02/2000WO2000011201A1 Targeted alphavirus and alphaviral vectors
03/02/2000WO2000011195A1 C-myc is activated by beta-catenin and tcf-4
03/02/2000WO2000011194A1 Cyclophilin-type peptidyl-prolyl cis/trans isomerase
03/02/2000WO2000011191A2 Tpl-2/cot kinase and methods of use
03/02/2000WO2000011189A1 Use of leu a promoter of stagonospora nodorum in screening method for fungicides
03/02/2000WO2000011186A1 Modified hcv peptide vaccines
03/02/2000WO2000011183A2 Chlamydia antigens and corresponding dna fragments and uses thereof
03/02/2000WO2000011174A1 Human il-1 epsilon dna and polypeptides
03/02/2000WO2000011171A2 Human rna-associated proteins
03/02/2000WO2000011170A1 14400 receptor, a g-protein coupled receptor
03/02/2000WO2000011169A2 Human cell signaling proteins (csig)
03/02/2000WO2000011167A2 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof
03/02/2000WO2000011166A1 14274 receptor, a g-protein coupled receptor related to the edg receptor family
03/02/2000WO2000011163A1 Dcr5, a bmp-binding protein, and applications thereof
03/02/2000WO2000011156A1 Method for isolating satellite sequence
03/02/2000WO2000011141A2 tRNA BINDING DOMAIN
03/02/2000WO2000011136A1 Fast measuring device of enzymatic activity
03/02/2000WO2000011034A1 A mutant of tissue factor pathway inhibitor, dna sequence and use for detecting thrombotic disorders
03/02/2000WO2000011028A2 Anti-inflammatory peptides derived from il-2 and analogues thereof
03/02/2000WO2000011024A2 Novel optical architectures for microvolume laser-scanning cytometers
03/02/2000WO2000011019A1 Conjugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agent
03/02/2000WO2000011018A1 Conjugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agents
03/02/2000WO2000011016A1 Dysferlin mutations
03/02/2000WO2000011014A1 49 human secreted proteins
03/02/2000WO2000010603A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
03/02/2000WO2000010588A2 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs
03/02/2000WO2000010587A1 Analogs of udp-murnac peptides, assays and kits
03/02/2000WO2000010583A1 Human histone deacetylase gene hd4
03/02/2000WO2000010579A1 Method for detection of biological factors in epidermis
03/02/2000WO2000010459A2 Device and method for preparing and preserving a personal cell bank, especially for genetic analyses involving dna analyses
03/02/2000WO1999064869A3 Back pain diagnosis and apparatus for use therein
03/02/2000WO1999064054A9 Multibinding inhibitors of topoisomerase
03/02/2000WO1999063937A3 Multivalent macrolide antibiotics
03/02/2000WO1999063116A3 Use of prothymosin in the diagnosis and treatment of endometriosis
03/02/2000WO1999061614A3 Human socs proteins
03/02/2000WO1999061604A3 A vector for gene trap, and a method for gene trapping by using the vector
03/02/2000WO1999059037A9 Methods of determining protein activity levels using gene expression profiles
03/02/2000WO1999058714A3 Method for screening for inhibitors and activators of type iii secretion machinery in gram-negative bacteria
03/02/2000WO1999058558A3 Cell signaling proteins
03/02/2000WO1999057315A3 Mmp-9 gene polymorphisms
03/02/2000WO1999057271A3 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides
03/02/2000WO1999057261A3 Human bmp-2 promoter and method for exploring bone-related substance by using the same
03/02/2000WO1999054496A3 Method for typing of hla alleles
03/02/2000WO1999054465A3 Gene encoding syntaxin interacting protein
03/02/2000WO1999049083A9 Diagnosis of disease state using mrna profiles in peripheral leukocytes
03/02/2000WO1999045108A3 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines
03/02/2000WO1999042620A9 Articles of manufacture and methods for staining biomolecules
03/02/2000WO1999042596A3 Phosphodiesterase 10
03/02/2000WO1999024578A3 Neisserial antigens
03/02/2000DE19940751A1 Apparatus for detecting light emissions comprises light-emitting matrix facing light-detection matrix, which together sandwich test substance
03/02/2000DE19838837A1 Zellspezifische Promoter des Entkopplungsproteins 3 Cell-specific promoter of uncoupling protein 3
03/02/2000DE19837678A1 Device for detection of bacterial, viral and/or fungal pathogens in infant stools and/or urine comprises test strip inserted into diaper
03/02/2000CA2341765A1 Trna binding domain
03/02/2000CA2341637A1 Chlamydia antigens and corresponding dna fragments and uses thereof
03/02/2000CA2341558A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
03/02/2000CA2341483A1 Use of pooled probes in genetic analysis
03/02/2000CA2341359A1 Novel optical architectures for microvolume laser-scanning cytometers
03/02/2000CA2341309A1 Use of mcrp for delivery of materials into cells
03/02/2000CA2340983A1 Optical oxidative enzyme-based sensors
03/02/2000CA2340884A1 49 human secreted proteins
03/02/2000CA2340785A1 Cyclophilin-type peptidyl-prolyl cis/trans isomerase
03/02/2000CA2340673A1 Method for detection of biological factors in epidermis
03/02/2000CA2340460A1 A mutant of tissue factor pathway inhibitor, dna sequence and use for detecting thrombotic disorders
03/02/2000CA2340459A1 C-myc is activated by beta-catenin and tcf-4
03/02/2000CA2340458A1 Fluorescence polarization in nucleic acid analysis
03/02/2000CA2340457A1 14400 receptor, a g-protein coupled receptor
03/02/2000CA2340334A1 14274 receptor, a g-protein coupled receptor related to the edg receptor family
03/02/2000CA2340284A1 Methods and systems for predicting protein function
03/02/2000CA2340277A1 Human rna-associated proteins
03/02/2000CA2340175A1 Subtle mitochondrial mutations as tumor markers
03/02/2000CA2339968A1 Dcr5, a bmp-binding protein, and applications thereof
03/02/2000CA2339871A1 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof
03/02/2000CA2339860A1 Human cell signaling proteins (csig)
03/02/2000CA2339037A1 Method for isolating satellite sequences
03/02/2000CA2339036A1 Tpl-2/cot kinase and methods of use
03/02/2000CA2338837A1 Assays, methods and means for modulating nuclear localisation
03/02/2000CA2338772A1 Enzyme activity screen with direct substrate reloading
03/02/2000CA2337905A1 Targeted alphavirus and alphaviral vectors
03/02/2000CA2336546A1 Method for determining polynucleotide sequence variations
03/02/2000CA2333490A1 Enzyme activity screen with substrate replacement
03/01/2000EP0982589A1 Method for testing the toxicity of chemical substances using gastropods
03/01/2000EP0982400A1 Human glycine transporter
03/01/2000EP0982398A1 Substrates for beta-lactamase and uses thereof
03/01/2000EP0982298A1 Novel functionalized hydrophilic acridinium esters
03/01/2000EP0981745A1 The use of a bone morphogenetic protein (bmp) receptor complex for screening
03/01/2000EP0981728A2 Radiolabeled farnesyl-protein transferase inhibitors
03/01/2000EP0981651A1 Detection of retroviral subtypes based upon envelope specific sequences
03/01/2000EP0981650A1 Molecular detection of chromosome aberrations
03/01/2000EP0981648A1 ANTISENSE INHIBITION OF ras GENE WITH CHIMERIC AND ALTERNATING OLIGONUCLEOTIDES
03/01/2000EP0981647A1 Electrophoretic analysis of molecules using immobilized probes
03/01/2000EP0981646A1 Enzymatic dna molecules
03/01/2000EP0981645A1 Characterising dna
03/01/2000EP0981644A1 An apc mutation associated with familial colorectal cancer in ashkenazi jews
03/01/2000EP0981643A2 Electronic-property probing of biological molecules at surfaces
03/01/2000EP0981642A1 Kappa b kinase, subunits thereof, and methods of using same
03/01/2000EP0981641A2 System for measuring the efficacy of a sterilization cycle
03/01/2000EP0981640A1 Methods for drug target screening